SUN Pharmaceutical Industries Limited Irbesartan Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Irbesartan Export Records India — #4 Exporter, 298 Shipments, $8.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Irbesartan

India Pharmaceutical Trade Intelligence

$106.3M123 Suppliers68 CountriesHS 30049079

ExportsIndia → UNITED STATES37.2%India → FRANCE15.4%

ImportsSPAIN → India$149.9K UNITED STATES → India$19.2K

#1 Buyer: MACLEODS PHARMA

SUN Pharmaceutical Industries Limited — Irbesartan Exporter #4 | $8.3M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Irbesartan Exporter Profile

Indian Pharmaceutical Exporter · #4 for Irbesartan · $8.3M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Irbesartan with $8.3M in export value and 298 verified shipments. SUN Pharmaceutical Industries Limited holds a 7.9% market share in Irbesartan exports across 13 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Irbesartan Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Irbesartan export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Irbesartan?

Country	Value	Shipments	Share
BELGIUM	$2.4M	149	44.7%
AUSTRALIA	$920.4K	67	17.3%
KENYA	$469.2K	16	8.8%
TANZANIA	$385.6K	14	7.2%
MYANMAR

Who Are the Top Buyers of Irbesartan from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$2.3M	144
ALPHAPHARM PTY LIMITED	AUSTRALIA	$253.8K	22
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$210.1K	14
SUN PHARMA EAST AFRICA LIMITED	KENYA	$207.3K	8
SUN PHARMA ANZ PTY LTD.	AUSTRALIA	$198.0K	23
SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$174.0K	9
SUN PHARMA ANZ PTY LTD	AUSTRALIA	$170.8K	7
TO THE ORDER	TANZANIA	$113.7K	3
M/S. SUN PHARMA CANADA INC	CANADA	$108.0K	12
M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$100.0K	2

SUN Pharmaceutical Industries Limited supplies Irbesartan to 45 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by ALPHAPHARM PTY LIMITED (AUSTRALIA) and MYIT MAHAR TRADING CO., LTD. (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Irbesartan Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 3	$226.2K	8
IROVEL 150 TABLETS (Irbesartan Tablets 1	$135.8K	8
ABISART TABS 300MG EACH FILM COATED TABLET CONTAINS IRBESARTAN PH EUR 300MG PACK Box2x15s	$119.3K	3
IRBESARTAN TABLETS 150MG ( IRBESARTAN SU	$113.5K	13
IRBESARTAN TABLETS 300MG ( IRBESARTAN SU	$85.4K	3
IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 300+12.5MG ( IRBES+COMP BASICS TAB 300+12.5MG ) EACH FILM COATED TABLET CONTAINS:	$82.2K	5
IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 1	$78.8K	5
ABISART TABS 300MG. EACH FILM COATED TABLET CONTAINS:IRBESARTAN PH.EUR. 300MG (PACK : BOX2X15S)	$76.7K	6
IRBESARTAN TABLETS 150MG ( IRBESARTAN CR	$67.0K	6
IROVEL 300 MG TABLETS IRBESARTAN TABLET	$64.1K	3

SUN Pharmaceutical Industries Limited exports 209 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 3 with 8 shipments worth $226.2K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Irbesartan Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MYLAN LABORATORIES LIMITED	$10.8M	217	5	$50.0K
1	MACLEODS PHARMACEUTICALS LTD	$8.9M	178	12	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$8.3M	298	13	$28.0K
5	ALEMBIC PHARMACEUTICALS LIMITED	$7.6M	189	2	$40.4K
3	CAPLIN POINT LABORATORIES LIMITED	$5.3M	106	9	$50.0K

SUN Pharmaceutical Industries Limited ranks #4 among 123 Indian Irbesartan exporters. Average shipment value of $28.0K compared to the market average of $473.0K. The closest competitors by value are MYLAN LABORATORIES LIMITED and MACLEODS PHARMACEUTICALS LTD.

Which Indian Ports Ship Irbesartan Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	284	10.6%
SAHAR AIR	197	7.4%
SAHAR AIR CARGO ACC (INBOM4)	170	6.4%
JNPT/ NHAVA SHEVA SEA	147	5.5%
DELHI AIR	135	5.1%
DELHI AIR CARGO ACC (INDEL4)	133	5.0%
JNPT	129	4.8%
MUNDRA SEA (INMUN1)	108	4.0%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Irbesartan Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 317 individual customs records matching SUN Pharmaceutical Industries Limited exporting Irbesartan, covering 209 formulations to 13 countries via 45 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 68+ countries, 366+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Irbesartan

Irbesartan

SUN Pharmaceutical Industries Limited — Irbesartan Exporter Profile

SUN Pharmaceutical Industries Limited — Irbesartan Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Irbesartan?

Who Are the Top Buyers of Irbesartan from SUN Pharmaceutical Industries Limited?

What Is India's Total Irbesartan Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Irbesartan Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Irbesartan Exporters?

What Irbesartan Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Irbesartan to Key Markets

Australia — TGA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Irbesartan Exporters?

Which Indian Ports Ship Irbesartan Exports?

What Other Cardiovascular Products Does SUN Pharmaceutical Industries Limited Export?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Irbesartan Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Irbesartan Export Data from SUN Pharmaceutical Industries Limited

Irbesartan Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source